Jefferies Financial Group’s United Therapeutics UTHR Stock Holding History

Jefferies Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.78M	Buy	6,975 +278	+4%	+$144K	0.03%	378
2026 Q2	$3.63M	Buy	6,697 +696	+12%	+$392K	0.02%	475
2026 Q1	$3.56M	Sell	6,001 -3,148	-34%	-$1.57M	0.02%	423
2025 Q4	$4.46M	Buy	+9,149	New	+$4.26M	0.02%	522
2024 Q3	–	Sell	-5,700	Closed	-$1.82M	–	1788
2024 Q2	$1.82M	Sell	5,700 -4,300	-43%	-$1.14M	0.02%	564
2024 Q1	$2.3M	Sell	10,000 -385	-4%	-$86.9K	0.02%	544
2023 Q4	$2.28M	Buy	+10,385	New	+$2.39M	0.01%	661
2023 Q2	–	Sell	-1,440	Closed	-$323K	–	2025
2023 Q1	$323K	Buy	+1,440	New	+$355K	﹤0.01%	1213

Other funds holding UTHR

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jefferies Financial Group's UTHR Position: Q3 2026 in Review

Jefferies Financial Group increased its United Therapeutics (UTHR) stake by 4.2% in Q3 2026, buying an estimated $144K and bringing the position to 6,975 shares worth $3.78M. The position accounts for 0.03% of the portfolio, ranked #378.

Jefferies Financial Group first reported a position in UTHR in Q1 2023 and has held it in 8 quarters since. The position peaked at $4.46M in Q4 2025. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Jefferies Financial Group held 6,975 shares of United Therapeutics worth $3.78M as of Q3 2026.
Jefferies Financial Group bought 278 United Therapeutics shares in Q3 2026, an estimated $144K.
United Therapeutics made up 0.03% of Jefferies Financial Group's portfolio in Q3 2026, its #378 holding.
Jefferies Financial Group first reported a position in United Therapeutics in Q1 2023 and has held it in 8 quarters since.
Jefferies Financial Group's United Therapeutics position peaked at $4.46M in Q4 2025.
673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.